Neoplastic diseases

Study of current trend of thoracic malignancy in young adults at a tertiary care center
Darshan Kumar Bajaj, Surya Kant, Richa Tyagi, Jyoti Bajpai, Abhishek Dubey, R A S Kushwaha, Ajay Kumar Verma, K Vignesh, Mona Asnani

European Respiratory Journal Sep 2020, 56 (suppl 64) 1690; DOI: 10.1183/13993003.congress-2020.1690
The features of rare pulmonary tumors and their surgical treatment
Vadim Pischik, Evgenii Zinchenko, Aleksander Kovalenko, Olga Maslak

European Respiratory Journal Sep 2020, 56 (suppl 64) 1707; DOI: 10.1183/13993003.congress-2020.1707
Does abdominal-pelvic CT detect occult malignancy in patients with unprovoked pulmonary embolism?
Bana Hawramy, Julian Ting, Dipansu Ghosh

European Respiratory Journal Sep 2020, 56 (suppl 64) 1868; DOI: 10.1183/13993003.congress-2020.1868
Use of NELSON screening to early detect lung cancer(LC) patients in the Portuguese population
Inês Sucena Pereira, Adelaide Alves, Daniel Coutinho, Telma Costa, Eloisa Silva, Sérgio Campainha, Margarida Dias, Ana Barroso

European Respiratory Journal Sep 2020, 56 (suppl 64) 1608; DOI: 10.1183/13993003.congress-2020.1608
Risk factors for impaired pulmonary function in adult survivors of childhood hematological and non-hematological malignancies
Lucia Spicuzza, Emanuela Cannata, Lisa Angileri, Giovanna Russo, Andrea Di Cataldo, Nunzio Crimi

European Respiratory Journal Sep 2020, 56 (suppl 64) 1664; DOI: 10.1183/13993003.congress-2020.1664
Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
Adriana-Maria Hiller, Magnus Ekström, Eeva Piitulainen, Anne Lindberg, Eva Rönmark, Hanan Tanash

European Respiratory Journal Sep 2020, 56 (suppl 64) 1124; DOI: 10.1183/13993003.congress-2020.1124
Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy
Valentine Mismetti, Georgia Karpathiou, Stavros Anevlavis, Olivier Tiffet, Francois Casteillo, Paschalis Ntolios, Tiffany Trouillon, Michel Peoc`h, Marios E. Froudarakis

European Respiratory Journal Sep 2020, 56 (suppl 64) 1146; DOI: 10.1183/13993003.congress-2020.1146
In patients with treatment-sensitive cancers, does systemic anti-cancer therapy increase the chance of malignant pleural effusion control?
Nina Holling, Sonia Patole, Andrew Medford, Nick Maskell, Anna Bibby

European Respiratory Journal Sep 2020, 56 (suppl 64) 1141; DOI: 10.1183/13993003.congress-2020.1141
Computed tomography evidence of lymphangitis associated to malignant pleural effusion: its prevalence and impact on survival
Olalla Castro Añón, Alexandra Dudina, Rachel Mercer, Eihab Bedawi, Vinneth George, David Mccracken, Rachelle Asciak, Maged Hassan, Rob Hallifax, Nicole Russel, Francisco Rodríguez-Panadero, Najib M Rahman

European Respiratory Journal Sep 2020, 56 (suppl 64) 1145; DOI: 10.1183/13993003.congress-2020.1145
Sensitivity of PD-L1 analysis from pleural effusion in non-small cell lung cancer
Lars Hagmeyer, Simon Herkenrath, Marcel Treml, Sandhya Matthes, Kerstin Richter, Khosro Hekmat, Matthias Heldwein, Stephan Schäfer, Reinhard Büttner, Marianne Engels, Winfried Randerath

European Respiratory Journal Sep 2020, 56 (suppl 64) 1149; DOI: 10.1183/13993003.congress-2020.1149

Main menu

User menu

Search

Neoplastic diseases

Pages

Contact us